[ Price : $8.95]
HHS unveils a broad, department-wide initiative aimed at speeding clinical research, reducing regulatory barriers, and attracting ...[ Price : $8.95]
Regenxbio reaches an agreement with FDA on a path toward a potential accelerated approval of Navsunli (clemidsogene lanparvovec-sn...[ Price : $8.95]
A new journal article finds substantial differences in how major international regulators evaluate and approve oncology drugs that...[ Price : $8.95]
Former FDA commissioner Scott Gottlieb urges federal health officials to restore scientific leadership at the agency's medical pro...[ Price : $8.95]
Former FDA Office of New Drugs director Peter Stein criticizes the agency's National Priority Voucher program at the DIA Global An...[ Price : $8.95]
An opinion article calls on FDA to establish a formal regulatory framework for evaluating vaccines as potential interventions to p...[ Price : $8.95]
Merck says FDA has approved an expanded indication for its pneumococcal conjugate vaccine, Capvaxive, allowing its use in children...[ Price : $8.95]
FDA approves a Beam Therapeutics IND for BEAM-304, allowing the company to begin clinical testing of its experimental base-editing...